Covered recipient · General Payments record
SOPHIA ZHANG
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2024
$271.30
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $271.30 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $118.45 | 1 |
| ABBVIE INC. | $49.30 | 3 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $36.98 | 2 |
| Arcutis Biotherapeutics, Inc. | $34.06 | 2 |
| E.R. Squibb & Sons, L.L.C. | $18.52 | 1 |
| Dermavant Sciences, Inc. | $13.99 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $271.30 | 10 |
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.79 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106395257 | CMS |
| ABBVIE INC. | $13.12 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106395259 | CMS |
| ABBVIE INC. | $17.39 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106395261 | CMS |
| Arcutis Biotherapeutics, Inc. | $17.00 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121074051 | CMS |
| Arcutis Biotherapeutics, Inc. | $17.06 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121074053 | CMS |
| Dermavant Sciences, Inc. | $13.99 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127947787 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.52 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101422660 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.09 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152203296 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.89 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152203298 | CMS |
| UCB, Inc. | $118.45 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143097849 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.